← Leaderboards
Gregory P Priebe
Brigham And Women'S Hospital
$4,791,718
Attributed
$4,791,718
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,568,498 · 5
By mechanism
U19$6,171,426 · 2
R01$2,351,551 · 1
K08$621,000 · 1
R21$424,521 · 1
Top collaborators
- Jay K Kolls1 shared
- Richard Malley1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Clare M Tempany$31,151,323
- Gerald B Pier$23,267,480
- Cynthia A Lemere$15,207,972
- Jeremiah D. Schuur$1,063,874
- Martha L Bulyk$30,445,996
Others in their field
Top investigators on “Pseudomonas Aeruginosa”
- Henry F Chambers · Duke University$46,515,637
- Vance G Fowler · Duke University$46,515,637
- Deborah T Hung · Massachusetts General Hospital$24,051,776
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Daniel J Wozniak · Ohio State University$19,184,613
- Alan R Hauser · Northwestern University$18,516,245
Research focus
Pseudomonas AeruginosaImmune ResponseAntigensVaccinesCellsInfectionPneumoniaProteinsT-LymphocyteVaccine EfficacyTransgenic MiceAntibodiesResponseMouse ModelPathogenImmunizationImmunityComplexPassive ImmunizationAcuteCystic FibrosisMechanical VentilationCd4 Positive T LymphocytesLaboratory Mouse
Grant awards (15)
Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)$4,776,780
U19 · FY2025 · AI
Multicomponent vaccines for Pseudomonas aeruginosa$1,394,646
U19 · FY2025 · AI · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$409,484
R01 · FY2013 · HL · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$430,130
R01 · FY2012 · HL · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$433,888
R01 · FY2011 · HL · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$433,300
R01 · FY2010 · HL · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$425,175
R01 · FY2009 · HL · contact PI
Mechanisms of adaptive immunity to P. aeruginosa in the lung$219,574
R01 · FY2009 · HL · contact PI
Adaptive immunity of P. aeruginosa in cystic fibrosis$196,033
R21 · FY2006 · HL · contact PI
Adaptive immunity of P. aeruginosa in cystic fibrosis$228,488
R21 · FY2005 · HL
Cellular immunity to P. aeruginosa candidate vaccines$128,520
K08 · FY2005 · AI
Cellular immunity to P. aeruginosa candidate vaccines$128,520
K08 · FY2004 · AI
Cellular immunity to P. aeruginosa candidate vaccines$128,520
K08 · FY2003 · AI
Cellular immunity to P. aeruginosa candidate vaccines$117,720
K08 · FY2002 · AI
Cellular immunity to P. aeruginosa candidate vaccines$117,720
K08 · FY2001 · AI